Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 123

    1.

    CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

    Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JS.

    Neurology. 2009 Nov 11. [Epub ahead of print]PMID: 19907013 [PubMed - as supplied by publisher]Related articles

    2.

    Determinants of survival in progressive multifocal leukoencephalopathy.

    Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR, Simpson DM, Prosperi M, De Luca A, Koralnik IJ.

    Neurology. 2009 Nov 10;73(19):1551-8.PMID: 19901246 [PubMed - in process]Related articles

    3.

    Selegiline and oxidative stress in HIV-associated cognitive impairment.

    Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, Sacktor N, Anderson C, Marra CM, Clifford DB; For the ACTG 5114 Team.

    Neurology. 2009 Nov 4. [Epub ahead of print]PMID: 19890073 [PubMed - as supplied by publisher]Related articles

    4.

    Role of metabolic syndrome components in HIV-associated sensory neuropathy.

    Ances BM, Vaida F, Rosario D, Marquie-Beck J, Ellis RJ, Simpson DM, Clifford DB, McArthur JC, Grant I, McCutchan JA; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Metabolic Study Group.

    AIDS. 2009 Nov 13;23(17):2317-22.PMID: 19823068 [PubMed - in process]Related articles

    5.

    Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

    Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R.

    N Engl J Med. 2009 Sep 10;361(11):1075-80.PMID: 19741228 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.

    Clifford DB, Smurzynski M, Park LS, Yeh TM, Zhao Y, Blair L, Arens M, Evans SR.

    Neurology. 2009 Jul 28;73(4):309-14.PMID: 19636051 [PubMed - indexed for MEDLINE]Related articles

    7.

    HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.

    Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, Musisi S, Katabira E, Ronald A, Clifford DB, Laeyendecker O, Quinn TC.

    Clin Infect Dis. 2009 Sep 1;49(5):780-6.PMID: 19622045 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.

    Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, McArthur JC, Robertson K; AIDS Clinical Trials Group 736 Study Team.

    AIDS. 2009 Jul 17;23(11):1359-66.PMID: 19424052 [PubMed - in process]Related articles

    9.

    Simplification of the research diagnosis of HIV-associated sensory neuropathy.

    Evans SR, Clifford DB, Kitch DW, Goodkin K, Schifitto G, McArthur JC, Simpson DM.

    HIV Clin Trials. 2008 Nov-Dec;9(6):434-9.PMID: 19203909 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda.

    Sacktor N, Nakasujja N, Skolasky RL, Robertson K, Musisi S, Ronald A, Katabira E, Clifford DB.

    Neurology. 2009 Jan 13;72(2):165-70.PMID: 19139369 [PubMed - indexed for MEDLINE]Related articles

    11.

    Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy.

    Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, McCutchan JA, Morgello S, Grant I; CHARTER Group.

    Ann Neurol. 2008 Nov;64(5):566-72.PMID: 19067367 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Low atazanavir concentrations in cerebrospinal fluid.

    Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I; CHARTER Group.

    AIDS. 2009 Jan 2;23(1):83-7.PMID: 19050389 [PubMed - indexed for MEDLINE]Related articles

    13.

    HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.

    Ances BM, Clifford DB.

    Curr Neurol Neurosci Rep. 2008 Nov;8(6):455-61.PMID: 18957181 [PubMed - indexed for MEDLINE]Related articles

    14.

    Natalizumab and PML: a risky business?

    Clifford DB.

    Gut. 2008 Oct;57(10):1347-9. No abstract available. PMID: 18791114 [PubMed - indexed for MEDLINE]Related articles

    15.

    HIV-associated neurocognitive disease continues in the antiretroviral era.

    Clifford DB.

    Top HIV Med. 2008 Jun-Jul;16(2):94-8.PMID: 18591717 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.

    Evans SR, Yeh TM, Sacktor N, Clifford DB, Simpson D, Miller EN, Ellis RJ, Valcour V, Marra CM, Millar L, Schifitto G; AIDS Clinical Trials Group and the Neurologic AIDS Research Consortium.

    HIV Clin Trials. 2007 Nov-Dec;8(6):437-46.PMID: 18042509 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system.

    Letendre SL, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson D, Alexander TJ, Durelle J, Heaton R, Grant I; CHARTER Group.

    J Neuroimmune Pharmacol. 2007 Mar;2(1):120-7. Epub 2007 Jan 3.PMID: 18040835 [PubMed - indexed for MEDLINE]Related articles

    18.

    Updated research nosology for HIV-associated neurocognitive disorders.

    Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

    Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.PMID: 17914061 [PubMed - indexed for MEDLINE]Related articles

    19.

    The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.

    Canter JA, Haas DW, Kallianpur AR, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Murdock DG, Hulgan T.

    Pharmacogenomics J. 2008 Feb;8(1):71-7. Epub 2007 Aug 7.PMID: 17684475 [PubMed - indexed for MEDLINE]Related articles

    20.

    HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity.

    Sacktor N, Nakasujja N, Robertson K, Clifford DB.

    Nat Clin Pract Neurol. 2007 Aug;3(8):436-43. Review.PMID: 17671521 [PubMed - indexed for MEDLINE]Related articles

    21.

    A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.

    Evans SR, Simpson DM, Kitch DW, King A, Clifford DB, Cohen BA, McArthur JC; Neurologic AIDS Research Consortium; AIDS Clinical Trials Group.

    PLoS One. 2007 Jul 25;2(6):e551.PMID: 17653259 [PubMed]Related articlesFree article

    22.

    A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

    Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB; ACTG A5090 Team.

    Neurology. 2007 Sep 25;69(13):1314-21. Epub 2007 Jul 25.PMID: 17652642 [PubMed - indexed for MEDLINE]Related articles

    23.

    Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.

    Zhou L, Kitch DW, Evans SR, Hauer P, Raman S, Ebenezer GJ, Gerschenson M, Marra CM, Valcour V, Diaz-Arrastia R, Goodkin K, Millar L, Shriver S, Asmuth DM, Clifford DB, Simpson DM, McArthur JC; NARC and ACTG A5117 Study Group.

    Neurology. 2007 Jun 12;68(24):2113-9.PMID: 17562831 [PubMed - indexed for MEDLINE]Related articles

    24.

    Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia.

    Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S.

    J Neurovirol. 2007;13(1):67-72.PMID: 17454450 [PubMed - indexed for MEDLINE]Related articles

    25.

    Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring.

    Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB.

    Lancet Neurol. 2007 May;6(5):431-41. Review.PMID: 17434098 [PubMed - indexed for MEDLINE]Related articles

    26.

    Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial.

    Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, Romero C.

    PLoS Clin Trials. 2007 Mar 30;2(3):e13.PMID: 17401456 [PubMed]Related articlesFree article

    27.

    Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.

    Lima MA, Marzocchetti A, Autissier P, Tompkins T, Chen Y, Gordon J, Clifford DB, Gandhi RT, Venna N, Berger JR, Koralnik IJ.

    J Virol. 2007 Apr;81(7):3361-8. Epub 2007 Jan 17. Erratum in: J Virol. 2007 Oct;81(19):10835. PMID: 17229701 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.

    Motsinger AA, Ritchie MD, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, Johnson VA, Pollard RB, Merigan TC, Hirsch MS, Donahue JP, Kim RB, Haas DW.

    Pharmacogenet Genomics. 2006 Nov;16(11):837-45.PMID: 17047492 [PubMed - indexed for MEDLINE]Related articles

    29.

    Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.

    Kallianpur AR, Hulgan T, Canter JA, Ritchie MD, Haines JL, Robbins GK, Shafer RW, Clifford DB, Haas DW.

    AIDS. 2006 Jul 13;20(11):1503-13.PMID: 16847405 [PubMed - indexed for MEDLINE]Related articles

    30.

    Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.

    Hulgan T, Hughes M, Sun X, Smeaton LM, Terry E, Robbins GK, Shafer RW, Clifford DB, McComsey GA, Canter JA, Morrow JD, Haas DW.

    J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):450-4.PMID: 16791116 [PubMed - indexed for MEDLINE]Related articles

    31.

    Histoplasmoma: isolated central nervous system infection with Histoplasma capsulatum in a patient with AIDS. Case report and brief review of the literature.

    Azizirad O, Clifford DB, Groger RK, Prelutsky D, Schmidt RE.

    Clin Neurol Neurosurg. 2007 Feb;109(2):176-81. Epub 2006 Jun 13.PMID: 16777317 [PubMed - indexed for MEDLINE]Related articles

    32.

    HIV neuropathy natural history cohort study: assessment measures and risk factors.

    Simpson DM, Kitch D, Evans SR, McArthur JC, Asmuth DM, Cohen B, Goodkin K, Gerschenson M, So Y, Marra CM, Diaz-Arrastia R, Shriver S, Millar L, Clifford DB; ACTG A5117 Study Group.

    Neurology. 2006 Jun 13;66(11):1679-87.PMID: 16769940 [PubMed - indexed for MEDLINE]Related articles

    33.

    Neurologic consequences of hepatitis C and human immunodeficiency virus coinfection.

    Clifford DB, Yang Y, Evans S.

    J Neurovirol. 2005;11 Suppl 3:67-71. Review.PMID: 16540458 [PubMed - indexed for MEDLINE]Related articles

    34.

    Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy.

    Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, Curfman B, Miszkiel K, Mueller-Lenke N, Sanchez E, Barkhof F, Radue EW, Jäger HR, Clifford DB.

    N Engl J Med. 2006 Mar 2;354(9):924-33.PMID: 16510746 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.

    Ribaudo HJ, Haas DW, Tierney C, Kim RB, Wilkinson GR, Gulick RM, Clifford DB, Marzolini C, Fletcher CV, Tashima KT, Kuritzkes DR, Acosta EP; Adult AIDS Clinical Trials Group Study.

    Clin Infect Dis. 2006 Feb 1;42(3):401-7. Epub 2005 Dec 27.PMID: 16392089 [PubMed - indexed for MEDLINE]Related articles

    36.

    Clinical validation of the NeuroScreen.

    Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson D, Yiannoutsos CT, Yang Y, Robertson K; Neurological AIDS Research Consortium; AIDS Clinical Trials Group Study Teams A5001 and A362.

    J Neurovirol. 2005 Dec;11(6):503-11.PMID: 16338744 [PubMed - indexed for MEDLINE]Related articles

    37.

    Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains.

    Khan A, Su C, German M, Storch GA, Clifford DB, Sibley LD.

    J Clin Microbiol. 2005 Dec;43(12):5881-7.PMID: 16333071 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.

    Clifford DB, Evans S, Yang Y, Acosta EP, Goodkin K, Tashima K, Simpson D, Dorfman D, Ribaudo H, Gulick RM.

    Ann Intern Med. 2005 Nov 15;143(10):714-21.PMID: 16287792 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.

    Haas DW, Smeaton LM, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, De Gruttola V, Pollard RB, Merigan TC, Hirsch MS, George AL Jr, Donahue JP, Kim RB.

    J Infect Dis. 2005 Dec 1;192(11):1931-42. Epub 2005 Nov 1.PMID: 16267764 [PubMed - indexed for MEDLINE]Related articles

    40.

    The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects.

    Clifford DB, Evans SR, Yang Y, Gulick RM.

    AIDS. 2005 Oct;19 Suppl 3:S64-71.PMID: 16251830 [PubMed - indexed for MEDLINE]Related articles

    41.

    Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.

    Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Kallianpur AR, Summar M, Canter JA.

    AIDS. 2005 Sep 2;19(13):1341-9.PMID: 16103764 [PubMed - indexed for MEDLINE]Related articles

    42.

    Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients.

    Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, McArthur JC, Symonds W, Romero C.

    J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):426-9.PMID: 16010165 [PubMed - indexed for MEDLINE]Related articles

    43.

    Atypical PML leading to a diagnosis of common variable immunodeficiency.

    Snyder MD, Storch GA, Clifford DB.

    Neurology. 2005 May 10;64(9):1661. No abstract available. PMID: 15883345 [PubMed - indexed for MEDLINE]Related articles

    44.

    Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, Clifford DB, Hulgan T, Marzolini C, Acosta EP.

    AIDS. 2004 Dec 3;18(18):2391-400.PMID: 15622315 [PubMed - indexed for MEDLINE]Related articles

    45.

    Part 2: history of 20th century neurology: decade by decade.

    Tyler K, York GK, Steinberg DA, Okun MS, Steinbach M, Satran R, Fine EJ, Manteghi T, Bleck TP, Swanson JW, Mishra S, Meador KJ, Clifford DB, Toole JF, Melson L.

    Ann Neurol. 2003;53 Suppl 4:S27-45. No abstract available. PMID: 12722088 [PubMed - indexed for MEDLINE]Related articles

    46.

    The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology.

    Cinque P, Koralnik IJ, Clifford DB.

    J Neurovirol. 2003;9 Suppl 1:88-92. Review.PMID: 12709878 [PubMed - indexed for MEDLINE]Related articles

    47.

    Challenges for clinical trials to treat progressive multifocal leukoencephalopathy.

    Clifford DB.

    J Neurovirol. 2003;9 Suppl 1:68-72. Review.PMID: 12709875 [PubMed - indexed for MEDLINE]Related articles

    48.

    Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.

    Avasarala JR, Cross AH, Clifford DB, Singer BA, Siegel BA, Abbey EE.

    Mult Scler. 2003 Feb;9(1):59-62.PMID: 12617270 [PubMed - indexed for MEDLINE]Related articles

    49.

    Effects of fructose-1,6-bisphosphate on morphological and functional neuronal integrity in rat hippocampal slices during energy deprivation.

    Izumi Y, Benz AM, Katsuki H, Matsukawa M, Clifford DB, Zorumski CF.

    Neuroscience. 2003;116(2):465-75.PMID: 12559101 [PubMed - indexed for MEDLINE]Related articles

    50.

    A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.

    Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM; Neurologic AIDS Research Consortium.

    Neurology. 2002 Nov 26;59(10):1568-73.PMID: 12451199 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...